The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan
about
Population genetics of malaria resistance in humansPrimaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquineSub-Saharan red cell antigen phenotypes and glucose-6-phosphate dehydrogenase deficiency variants in French GuianaMalaria-related anaemia: a Latin American perspectivePrimaquine in vivax malaria: an update and review on management issuesThe anaemia of Plasmodium vivax malariaAdvances in genetics and genomics: use and limitations in achieving malaria elimination goalsEpidemiology and Control of Plasmodium vivax in AfghanistanG6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based mapG6PD deficiency in Latin America: systematic review on prevalence and variantsGlobal Epidemiology of Plasmodium vivaxThe challenges of introducing routine G6PD testing into radical cure: a workshop report.Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literatureMalaria parasites and red cell variants: when a house is not a home.Factors that are associated with the risk of acquiring Plasmodium knowlesi malaria in Sabah, Malaysia: a case-control study protocol.Potential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling questionThe Rate of Plasmodium vivax Infectivity within Gloucose-6-Phosphate Dehydrogenase (G6PD) Deficient Individuals in Hormozgan Province, Iran.A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in AfghanistanG6PD gene variants and its association with malaria in a Sri Lankan population.Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiencyComplexity of Infection and Genetic Diversity in Cambodian Plasmodium vivax.PharmGKB summary: very important pharmacogene information for G6PD.Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the PhilippinesIn vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region.Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency.Red blood cell polymorphism and susceptibility to Plasmodium vivax.Key Knowledge Gaps for Plasmodium vivax Control and EliminationCharacterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malariaAssociation of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis.Frequency of G6PD Mediterranean in individuals with and without malaria in Southern Pakistan.G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose?Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.Individual-level factors associated with the risk of acquiring human Plasmodium knowlesi malaria in Malaysia: a case-control study.Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.malaria: current research perspectives
P2860
Q21032506-6534F937-760D-4047-8425-A5E7F0FB6E5BQ24202900-A40F04F6-82FE-401E-B3FA-342425B0F68DQ24570079-5ABAB1FD-D3AE-4109-B025-D02C9E637CEAQ26997119-C36A137A-CD13-409C-9061-A3F5CCA1D093Q27003856-44F4810E-0E93-49B7-80CD-6578D8542B51Q27026970-F00D1481-FBA8-4BF8-9BE2-6B8ABE56EE1DQ28082023-021C0DB9-230D-4AA4-A628-08F1426EF420Q28355710-77D66386-9D61-4E35-A8AC-D88704667C7DQ28485156-0A0127CE-ECAB-4166-B679-E88465F54E3AQ29353696-CF06F083-6BD0-4E16-8B4D-D25C22A865C2Q30249044-A8AD569B-ABFD-49FD-A245-FE3B1F090010Q30666192-AD720C7C-2915-4FEC-B629-717BA2DED5DBQ33399080-3C83BC5B-1AAB-4FE4-891F-D71E3B2CEE9CQ33851100-9000D72E-5114-43F1-A9CC-DCBC2E361940Q34144960-CFD04049-0502-4AD0-B573-C7B4276D9BE4Q34298686-0CEE1AF0-0A85-4283-A074-645EBFA89009Q35047350-7ACDA889-F692-4AE2-97D3-C47DD51E6F45Q35106171-F4146D0D-502F-413F-A089-9DA429E821D3Q35129368-7F1F0D06-C742-41F5-A593-13C73C3FB2DEQ35754020-6C013DC3-6BF0-4C77-A736-2ECAB16BF5E4Q35971244-8B6DB933-D8D7-48BD-BE1C-BE5C681F4AE4Q36055205-5775F9B2-4B15-44F1-8C52-ECC20C66DBDFQ36267671-73BDD18A-2E9B-400A-89D2-BBFC5EF1FD2CQ36337171-EB32B8B7-55AC-445E-8A5E-50E5B52F9842Q36551751-7FA63A61-6367-4D65-92BF-67B17B350D50Q36667032-93D65B4C-6E15-4A4E-AAA5-07824E19832DQ37009492-848B5F25-CA0C-4CF7-8750-3843419482F3Q37058082-5058C496-3F01-40A6-9E2B-3B17D8A12F48Q37058815-312DF3A0-0B7A-46D4-9C64-BC9DA988CB18Q37546198-6126D826-ECFD-409A-BA68-2E4FCFD49FDFQ37574319-76C1886B-C36F-42E2-B3FA-9C3A94764884Q37728609-9705F7DE-EB3E-4D6D-AD74-817531414C39Q37739562-132C4E42-DDBB-4DE3-B860-0CA75E977A28Q42634030-A4336ACE-047C-4765-A4F6-5D0ABE1B38B0Q43721671-54106253-04B6-42D5-BCB1-682EAB69AD86Q46179000-8D4E122A-D41B-40F6-899F-B20149B639EDQ48016667-94ABB8DB-4613-48D2-877E-9EF651505FAEQ52872251-58973F6D-7E8A-451A-8C2A-35F6DCD4E002Q55212289-3A24C6D6-AAF1-4264-97EA-7D2AA44E4601Q56344544-25903251-0D26-4F97-8EA1-B1EAD7F5307F
P2860
The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@ast
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@en
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@nl
type
label
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@ast
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@en
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@nl
prefLabel
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@ast
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@en
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@nl
P2093
P2860
P3181
P1433
P1476
The impact of phenotypic and g ...... st Afghan refugees in Pakistan
@en
P2093
Carol Hopkins Sibley
Eveline Klinkenberg
Ismail Mayan
Marnie Briceño
Nasir Mohammed
Toby Leslie
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1000283
P407
P577
2010-05-25T00:00:00Z